Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1971 Mar;47(545):141–155. doi: 10.1136/pgmj.47.545.141

Immunological studies on Burkitt's lymphoma.

G Klein
PMCID: PMC2466873  PMID: 4932902

Full text

PDF
141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlström C. G., Andersson T., Klein G., Akerman M. Malignant lymphoma of "Burkitt type" in Sweden. Int J Cancer. 1967 Nov 15;2(6):583–585. doi: 10.1002/ijc.2910020607. [DOI] [PubMed] [Google Scholar]
  2. Bremberg S., Klein G., Epstein A. Direct membrane fluorescence reaction of EBV-carrying human lymphoblastoid cells: blocking tests with xenogeneic antisera. Int J Cancer. 1969 Nov 15;4(6):761–766. doi: 10.1002/ijc.2910040603. [DOI] [PubMed] [Google Scholar]
  3. Burger M. M. Isolation of a receptor complex for a tumor specific agglutinin from the neoplastic cell surface. Nature. 1968 Aug 3;219(5153):499–500. doi: 10.1038/219499a0. [DOI] [PubMed] [Google Scholar]
  4. Burkitt D. P. Etiology of Burkitt's lymphoma--an alternative hypothesis to a vectored virus. J Natl Cancer Inst. 1969 Jan;42(1):19–28. [PubMed] [Google Scholar]
  5. Burkitt D. P., Kyalwazi S. K. Spontaneous remission of African lymphoma. Br J Cancer. 1967 Mar;21(1):14–16. doi: 10.1038/bjc.1967.2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Churchill A. E. Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. I. Studies in cell culture. J Natl Cancer Inst. 1968 Oct;41(4):939–950. [PubMed] [Google Scholar]
  7. Clifford P. Further studies on the treatment of Burkitt's lymphoma. East Afr Med J. 1966 Jun;43(6):179–199. [PubMed] [Google Scholar]
  8. Clifford P., Gripenberg U., Klein E., Fenyo E. M., Manolov G. Treatment of Burkitt's lymphoma. Lancet. 1968 Aug 31;2(7566):517–518. doi: 10.1016/s0140-6736(68)90681-8. [DOI] [PubMed] [Google Scholar]
  9. Deichman G. I. Immunological aspects of carcinogenesis by deoxyribonucleic acid tumor viruses. Adv Cancer Res. 1969;12:101–136. doi: 10.1016/s0065-230x(08)60329-2. [DOI] [PubMed] [Google Scholar]
  10. EPSTEIN M. A., ACHONG B. G., BARR Y. M. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet. 1964 Mar 28;1(7335):702–703. doi: 10.1016/s0140-6736(64)91524-7. [DOI] [PubMed] [Google Scholar]
  11. Einhorn N., Klein G., Clifford P. Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation. Cancer. 1970 Nov;26(5):1013–1021. doi: 10.1002/1097-0142(197011)26:5<1013::aid-cncr2820260508>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  12. Epstein M. A., Achong B. G., Barr Y. M., Zajac B., Henle G., Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst. 1966 Oct;37(4):547–559. [PubMed] [Google Scholar]
  13. Fenyö E. M., Klein E., Klein G., Swiech K. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens. J Natl Cancer Inst. 1968 Jan;40(1):69–89. [PubMed] [Google Scholar]
  14. Fialkow P. J., Klein G., Gartler S. M., Clifford P. Clonal origin for individual Burkitt tumours. Lancet. 1970 Feb 21;1(7643):384–386. doi: 10.1016/s0140-6736(70)91517-5. [DOI] [PubMed] [Google Scholar]
  15. France: space effort declines. Nature. 1970 Dec 12;228(5276):1016–1017. doi: 10.1038/2281016b0. [DOI] [PubMed] [Google Scholar]
  16. Gerper P., Whang-Peng J., Monroe J. H. Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures. Proc Natl Acad Sci U S A. 1969 Jul;63(3):740–747. doi: 10.1073/pnas.63.3.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goldstein G., Klein G., Pearson G., Clifford P. Direct membrane immunofluorescence reaction of Burkitt's lymphoma cells in culture. Cancer Res. 1969 Apr;29(4):749–752. [PubMed] [Google Scholar]
  18. Gunvén P., Klein G., Henle G., Henle W., Clifford P. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Nature. 1970 Dec 12;228(5276):1053–1056. doi: 10.1038/2281053a0. [DOI] [PubMed] [Google Scholar]
  19. HAUSCHKA T. S., KVEDAR B. J., GRINNELL S. T., AMOS D. B. Immunoselection of polyploids from predominantly diploid cell populations. Ann N Y Acad Sci. 1956 Mar 14;63(5):683–705. doi: 10.1111/j.1749-6632.1956.tb50886.x. [DOI] [PubMed] [Google Scholar]
  20. Hellström I., Hellström K. E. Colony inhibition studies on blocking and non-blocking serum effects on cellular immunity to Moloney sarcomas. Int J Cancer. 1970 Mar 15;5(2):195–201. doi: 10.1002/ijc.2910050205. [DOI] [PubMed] [Google Scholar]
  21. Hellström I., Hellström K. E., Evans C. A., Heppner G. H., Pierce G. E., Yang J. P. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A. 1969 Feb;62(2):362–368. doi: 10.1073/pnas.62.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hellström K. E., Hellström I. Cellular immunity against tumor antigens. Adv Cancer Res. 1969;12:167–223. doi: 10.1016/s0065-230x(08)60331-0. [DOI] [PubMed] [Google Scholar]
  23. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M., Pike P. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969 Nov;43(5):1147–1157. [PubMed] [Google Scholar]
  24. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Henle G., Henle W. Immunofluorescence, interference, and complement fixation technics in the detection of the herpes-type virus in Burkitt tumor cell lines. Cancer Res. 1967 Dec;27(12):2442–2446. [PubMed] [Google Scholar]
  27. Henle W., Diehl V., Kohn G., Zur Hausen H., Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 1967 Sep 1;157(3792):1064–1065. doi: 10.1126/science.157.3792.1064. [DOI] [PubMed] [Google Scholar]
  28. Henle W., Henle G., Ho H. C., Burtin P., Cachin Y., Clifford P., de Schryver A., de-Thé G., Diehl V., Klein G. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst. 1970 Jan;44(1):225–231. [PubMed] [Google Scholar]
  29. Henle W., Henle G., Zajac B. A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 1970 Jul 10;169(3941):188–190. doi: 10.1126/science.169.3941.188. [DOI] [PubMed] [Google Scholar]
  30. Hunt R. D., Meléndez L. V., King N. W., Gilmore C. E., Daniel M. D., Williamson M. E., Jones T. C. Morphology of a disease with features of malignant lymphoma in marmosets and owl monkeys inoculated with Herpesvirus saimiri. J Natl Cancer Inst. 1970 Feb;44(2):447–465. [PubMed] [Google Scholar]
  31. Inbar M., Sachs L. Structural difference in sites on the surface membrane of normal and transformed cells. Nature. 1969 Aug 16;223(5207):710–712. doi: 10.1038/223710a0. [DOI] [PubMed] [Google Scholar]
  32. Johansson B., Klein E. Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia. Clin Exp Immunol. 1970 Mar;6(3):421–428. [PMC free article] [PubMed] [Google Scholar]
  33. Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer. 1970 Nov 15;6(3):450–462. doi: 10.1002/ijc.2910060316. [DOI] [PubMed] [Google Scholar]
  34. KLEIN E., KLEIN G. ANTIGENIC PROPERTIES OF LYMPHOMAS INDUCED BY THE MOLONEY AGENT. J Natl Cancer Inst. 1964 Mar;32:547–568. [PubMed] [Google Scholar]
  35. KLEIN G., SJOGREN H. O., KLEIN E., HELLSTROM K. E. Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host. Cancer Res. 1960 Dec;20:1561–1572. [PubMed] [Google Scholar]
  36. Kafuko G. W., Burkitt D. P. Burkitt's lymphoma and malaria. Int J Cancer. 1970 Jul 15;6(1):1–9. doi: 10.1002/ijc.2910060102. [DOI] [PubMed] [Google Scholar]
  37. Klein E., Clifford P., Klein G., Hamberger C. A. Further studies on the membrane immunofluorescence reaction of Burkitt lymphoma cells. Int J Cancer. 1967 Jan 15;2(1):27–36. doi: 10.1002/ijc.2910020106. [DOI] [PubMed] [Google Scholar]
  38. Klein E., Eskeland T., Inoue M., Strom R., Johansson B. Surface immunoglobulin-moieties on lymphoid cells. Exp Cell Res. 1970 Sep;62(1):133–148. doi: 10.1016/0014-4827(79)90515-9. [DOI] [PubMed] [Google Scholar]
  39. Klein E., Klein G., Nadkarni J. S., Nadkarni J. J., Wigzell H., Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 1968 Jul;28(7):1300–1310. [PubMed] [Google Scholar]
  40. Klein G., Clifford P., Henle G., Henle W., Geering G., Old L. J. EBV-associated serological patterns in a Burkitt lymphoma patient during regression and recurrence. Int J Cancer. 1969 Jul 15;4(4):416–421. doi: 10.1002/ijc.2910040406. [DOI] [PubMed] [Google Scholar]
  41. Klein G., Clifford P., Klein E., Smith R. T., Minowada J., Kourilsky F. M., Burchenal J. H. Membrane immunofluorescence reactions of Burkitt lymphoma cells from biopsy specimens and tissue cultures. J Natl Cancer Inst. 1967 Nov;39(5):1027–1044. [PubMed] [Google Scholar]
  42. Klein G., Clifford P., Klein E., Stjernswärd J. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc Natl Acad Sci U S A. 1966 Jun;55(6):1628–1635. doi: 10.1073/pnas.55.6.1628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Klein G. Experimental studies in tumor imminology. Fed Proc. 1969 Nov-Dec;28(6):1739–1753. [PubMed] [Google Scholar]
  44. Klein G., Geering G., Old L. J., Henle G., Henle W., Clifford P. Comparison of the anti-EBV titer and the EBV-associated membrane reactive and precipitating antibody levels in the sera of Burkitt lymphoma and nasopharyngeal carcinoma patients and controls. Int J Cancer. 1970 Mar 15;5(2):185–194. doi: 10.1002/ijc.2910050204. [DOI] [PubMed] [Google Scholar]
  45. Klein G., Klein E., Clifford P. Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines. Cancer Res. 1967 Dec;27(12):2510–2520. [PubMed] [Google Scholar]
  46. Klein G., Klein E., Haughton G. Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus. J Natl Cancer Inst. 1966 Apr;36(4):607–621. doi: 10.1093/jnci/36.4.607. [DOI] [PubMed] [Google Scholar]
  47. Klein G., Pearson G., Henle G., Henle W., Goldstein G., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J Exp Med. 1969 Apr 1;129(4):697–705. doi: 10.1084/jem.129.4.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Klein G., Pearson G., Nadkarni J. S., Nadkarni J. J., Klein E., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J Exp Med. 1968 Nov 1;128(5):1011–1020. doi: 10.1084/jem.128.5.1011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Levin A. G., Friberg S., Jr, Klein E. Xenotransplantation of a Burkitt lymphoma culture line with surface immunoglobulin specificity. Nature. 1969 Jun 7;222(5197):997–998. doi: 10.1038/222997a0. [DOI] [PubMed] [Google Scholar]
  50. Macpherson I. The characteristics of animal cells transformed in vitro. Adv Cancer Res. 1970;13:169–215. doi: 10.1016/s0065-230x(08)60166-9. [DOI] [PubMed] [Google Scholar]
  51. Mathé G. Approaches to the immunological treatment of cancer in man. Br Med J. 1969 Oct 4;4(5674):7–10. doi: 10.1136/bmj.4.5674.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Meyer G., Birg F., Bonneau H. Cinétique de l'antigène de membrane dans le système virus polyome-hamster. C R Acad Sci Hebd Seances Acad Sci D. 1969 Jun 3;268(23):2848–2849. [PubMed] [Google Scholar]
  53. Mizell M., Toplin I., Isaacs J. J. Tumor induction in developing frog kidneys by a zonal centrifuge purified fraction of the frog herpes-type virus. Science. 1969 Sep 12;165(3898):1134–1137. doi: 10.1126/science.165.3898.1134. [DOI] [PubMed] [Google Scholar]
  54. Mora P. T., Brady R. O., Bradley R. M., McFarland V. W. Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1290–1296. doi: 10.1073/pnas.63.4.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Möller G. DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE. J Exp Med. 1961 Sep 30;114(4):415–434. doi: 10.1084/jem.114.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. NGU V. A. THE AFRICAN LYMPHOMA (BURKITT TUMOUR): SURVIVALS EXCEEDING TWO YEARS. Br J Cancer. 1965 Mar;19:101–107. doi: 10.1038/bjc.1965.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Nadkarni J. S., Nadkarni J. J., Klein G., Henle W., Henle G., Clifford P. EB viral antigens in Burkitt tumor biopsies and early cultures. Int J Cancer. 1970 Jul 15;6(1):10–17. doi: 10.1002/ijc.2910060103. [DOI] [PubMed] [Google Scholar]
  58. Niederman J. C., Evans A. S., Subrahmanyan L., McCollum R. W. Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med. 1970 Feb 12;282(7):361–365. doi: 10.1056/NEJM197002122820704. [DOI] [PubMed] [Google Scholar]
  59. OLD L. J., BOYSE E. A. IMMUNOLOGY OF EXPERIMENTAL TUMORS. Annu Rev Med. 1964;15:167–186. doi: 10.1146/annurev.me.15.020164.001123. [DOI] [PubMed] [Google Scholar]
  60. Old L. J., Boyse E. A., Geering G., Oettgen H. F. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 1968 Jul;28(7):1288–1299. [PubMed] [Google Scholar]
  61. Old L. J., Boyse E. A., Oettgen H. F., Harven E. D., Geering G., Williamson B., Clifford P. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699–1704. doi: 10.1073/pnas.56.6.1699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. PARKER J. C., TENNANT R. W., WARD T. G., ROWE W. P. VIRUS STUDIES WITH GERMFREE MICE. I. PREPARATION OF SEROLOGIC DIAGNOSTIC REAGENTS AND SURVEY OF GERMFREE AND MONOCONTAMINATED MICE FOR INDIGENOUS MURINE VIRUSES. J Natl Cancer Inst. 1965 Mar;34:371–380. [PubMed] [Google Scholar]
  63. Pasternak G. Antigens induced by the mouse leukemia viruses. Adv Cancer Res. 1969;12:1–99. doi: 10.1016/s0065-230x(08)60328-0. [DOI] [PubMed] [Google Scholar]
  64. Pearson G., Dewey F., Klein G., Henle G., Henle W. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. J Natl Cancer Inst. 1970 Nov;45(5):989–995. [PubMed] [Google Scholar]
  65. Pearson G., Klein G., Henle G., Henle W., Clifford P. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence. J Exp Med. 1969 Apr 1;129(4):707–718. doi: 10.1084/jem.129.4.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Pollack R. E., Green H., Todaro G. J. Growth control in cultured cells: selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. Proc Natl Acad Sci U S A. 1968 May;60(1):126–133. doi: 10.1073/pnas.60.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Pope J. H., Horne M. K., Scott W. Identification of the filtrable leukocyte-transforming factor of QIMR-WIL cells as herpes-like virus. Int J Cancer. 1969 May 15;4(3):255–260. doi: 10.1002/ijc.2910040302. [DOI] [PubMed] [Google Scholar]
  68. RAPP F., BUTEL J. S., FELDMAN L. A., KITAHARA T., MELNICK J. L. DIFFERENTIAL EFFECTS OF INHIBITORS ON THE STEPS LEADING TO THE FORMATION OF SV40 TUMOR AND VIRUS ANTIGENS. J Exp Med. 1965 Jun 1;121:935–944. doi: 10.1084/jem.121.6.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Rabinowitz Z., Sachs L. The formation of variants with a reversion of properties of transformed cells. IV. Loss of detectable polyoma transplantation antigen. Virology. 1970 Feb;40(2):193–198. doi: 10.1016/0042-6822(70)90394-6. [DOI] [PubMed] [Google Scholar]
  70. Rubin H. A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS. Proc Natl Acad Sci U S A. 1960 Aug;46(8):1105–1119. doi: 10.1073/pnas.46.8.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. STUECK B., OLD L. J., BOYSE E. A. ANTIGENIC CONVERSION OF ESTABLISHED LEUKEMIAS BY AN UNRELATED LEUKAEMOGENIC VIRUS. Nature. 1964 Jun 6;202:1016–1018. doi: 10.1038/2021016b0. [DOI] [PubMed] [Google Scholar]
  72. Sjögren H. O., Hellström I. Induction of polyoma specific transplantation antigenicity in Moloney leukemia cells. Exp Cell Res. 1965 Oct;40(1):208–212. doi: 10.1016/0014-4827(65)90319-8. [DOI] [PubMed] [Google Scholar]
  73. Sjögren H. O. Transplantation methods as a tool for detection of tumor-specific antigens. Prog Exp Tumor Res. 1965;6:289–322. [PubMed] [Google Scholar]
  74. Skipper H. E. Criteria associated with destruction of leukemia and solid tumor cells in animals. Cancer Res. 1967 Dec;27(12):2636–2645. [PubMed] [Google Scholar]
  75. Southam C. M., Tanaka S., Arata T., Simkovic D., Miura M., Petropulos S. F. Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. Prog Exp Tumor Res. 1969;11:194–212. doi: 10.1159/000391394. [DOI] [PubMed] [Google Scholar]
  76. Stjernsward J., Clifford P., Singh S., Svedmyr E. Indications of cellular immunological reactions against autochthonous tumour in cancer patients studied in vitro. East Afr Med J. 1968 Jul;45(7):484–497. [PubMed] [Google Scholar]
  77. Svedmyr A., Demissie A., Klein G., Clifford P. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus. J Natl Cancer Inst. 1970 Mar;44(3):595–610. [PubMed] [Google Scholar]
  78. Svet-Moldavsky G. J., Mkheidze D. M., Liozner A. L. Two phenomena associated with skin grafting from tumor-bearing syngeneic donors. J Natl Cancer Inst. 1967 Jun;38(6):933–938. [PubMed] [Google Scholar]
  79. Yata J., Klein G., Hewetson J., Gergely L. Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established Burkitt lymphoma cell lines. Int J Cancer. 1970 May 15;5(3):394–403. doi: 10.1002/ijc.2910050314. [DOI] [PubMed] [Google Scholar]
  80. Yata J., Klein G. Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines. Int J Cancer. 1969 Nov 15;4(6):767–775. doi: 10.1002/ijc.2910040604. [DOI] [PubMed] [Google Scholar]
  81. Zur Hausen H., Schulte-Holthausen H. Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells. Nature. 1970 Jul 18;227(5255):245–248. doi: 10.1038/227245a0. [DOI] [PubMed] [Google Scholar]
  82. de Schryver A., Friberg S., Jr, Klein G., Henle W., Henle G., De-Thé G., Clifford P., Ho H. C. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. Clin Exp Immunol. 1969 Nov;5(5):443–459. [PMC free article] [PubMed] [Google Scholar]
  83. de Thé G., de Schryver A., Klein G. Surface antigens on lymphoblastoid cells derived from nasopharyngeal carcinoma. Clin Exp Immunol. 1970 Aug;7(2):161–171. [PMC free article] [PubMed] [Google Scholar]
  84. zur Hausen H., Henle W., Hummeler K., Diehl V., Henle G. Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol. 1967 Aug;1(4):830–837. doi: 10.1128/jvi.1.4.830-837.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES